Cancer BiologyMolecular Systems BiologyPeer-reviewed
A novel combination therapy for ER+ breast cancer suppresses drug resistance via an evolutionary double-bind
Rena Emond, Jeffrey West, Vince Kornél Grolmusz…·Andrea H. Bild
The paper develops a combination therapy for ER+ breast cancer that uses an evolutionary double-bind strategy to suppress drug resistance.
DOI 10.1038/s44320-026-00191-z